Volume 15, Number 5—May 2009
Dispatch
Reduced Fluoroquinolone Susceptibility in Salmonella enterica Isolates from Travelers, Finland
Table
Quinolone susceptibility of 499 Salmonella isolates collected from travelers returning to Finland, by country visited, 2003−2007*
Country visited | No. (%) isolates | No. isolates with CIP MIC >0.125 µg/mL | No. isolates with NAL MIC >32 µg/mL | No. isolates with NAL MIC <32 µg/mL | No. trips from Finland during study months† |
---|---|---|---|---|---|
Thailand‡ | 212 (42.5) | 98 | 67 | 31 | 122,472 |
Spain§ | 66 (13.2) | 25 | 25 | 0 | 426,822 |
Brazil | 41 (8.2) | 0 | 0 | 0 | 25,009 |
Egypt | 40 (8.0) | 17 | 17 | 0 | 47,291 |
India | 32 (6.4) | 7 | 7 | 0 | 26,233 |
Malaysia | 15 (3.0) | 6 | 1 | 5 | 2,597 |
Vietnam | 9 (1.8) | 2 | 2 | 0 | 7,555 |
Tanzania | 9 (1.8) | 2 | 2 | 0 | 1,259 |
Portugal | 8 (1.6) | 7 | 7 | 0 | 35,899 |
Morocco | 5 (1.0) | 3 | 3 | 0 | 8,708 |
Other areas |
62 (12.4) |
14 |
14 |
0 |
|
Total | 499 (100) | 181 | 145 | 36 |
*CIP, ciprofloxacin; NAL, nalidixic acid.
†Data collected from statistics reports, Finland, based on the no. of Finnish travelers to these countries.
‡No. Finnish travelers to Thailand from 2003 to 2007: 21,873; 22,882; 17,661; 21,941; and 38,115, respectively.
§Includes Canary Islands.